论文信息 - GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial. - 字舞流文

GS-101 antisense oligonucleotide eye drops inhibit corneal neovascularization: interim results of a randomized phase II trial.

F. Horn | D. Meller | B. Seitz | M. Thiel | F. Kruse | K. Steuhl | C. Cursiefen | V. Borderie | F. Bock | B. Geudelin | F. Wilhelm | B. Früh | Isabelle Descohand | A. Hahn